About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Molecular Diagnostics Market Size, Top Share, Demand, Forecast to 2032
Molecular Diagnostics Market

Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product & Service (Reagents And Kits, Instruments, Software & Services), By Technology (PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarrays, Other), By Applications (Infectious Disease Diagnostics, Oncology Testing, Genetic Tests, Others), By End User (Hospitals and Academic Laboratories, Reference Laboratories, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI29DR
Last Updated : December 10, 2024
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Molecular Diagnostics Market Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Reagents And Kits
        1. By Value
      3. Instruments
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. INAAT
        1. By Value
      4. DNA Sequencing & NGS
        1. By Value
      5. In Situ Hybridization
        1. By Value
      6. DNA Microarrays
        1. By Value
      7. Other
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Diagnostics
        1. By Value
      3. Oncology Testing
        1. By Value
      4. Genetic Tests
        1. By Value
      5. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Academic Laboratories
        1. By Value
      3. Reference Laboratories
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Reagents And Kits
        1. By Value
      3. Instruments
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. INAAT
        1. By Value
      4. DNA Sequencing & NGS
        1. By Value
      5. In Situ Hybridization
        1. By Value
      6. DNA Microarrays
        1. By Value
      7. Other
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Diagnostics
        1. By Value
      3. Oncology Testing
        1. By Value
      4. Genetic Tests
        1. By Value
      5. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Academic Laboratories
        1. By Value
      3. Reference Laboratories
        1. By Value
      4. Others
        1. By Value
    6. U.S.
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Reagents And Kits
          1. By Value
        3. Instruments
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. INAAT
          1. By Value
        4. DNA Sequencing & NGS
          1. By Value
        5. In Situ Hybridization
          1. By Value
        6. DNA Microarrays
          1. By Value
        7. Other
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Diagnostics
          1. By Value
        3. Oncology Testing
          1. By Value
        4. Genetic Tests
          1. By Value
        5. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Academic Laboratories
          1. By Value
        3. Reference Laboratories
          1. By Value
        4. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Reagents And Kits
        1. By Value
      3. Instruments
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. INAAT
        1. By Value
      4. DNA Sequencing & NGS
        1. By Value
      5. In Situ Hybridization
        1. By Value
      6. DNA Microarrays
        1. By Value
      7. Other
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Diagnostics
        1. By Value
      3. Oncology Testing
        1. By Value
      4. Genetic Tests
        1. By Value
      5. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Academic Laboratories
        1. By Value
      3. Reference Laboratories
        1. By Value
      4. Others
        1. By Value
    6. U.K.
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Reagents And Kits
          1. By Value
        3. Instruments
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. INAAT
          1. By Value
        4. DNA Sequencing & NGS
          1. By Value
        5. In Situ Hybridization
          1. By Value
        6. DNA Microarrays
          1. By Value
        7. Other
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Diagnostics
          1. By Value
        3. Oncology Testing
          1. By Value
        4. Genetic Tests
          1. By Value
        5. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Academic Laboratories
          1. By Value
        3. Reference Laboratories
          1. By Value
        4. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Reagents And Kits
        1. By Value
      3. Instruments
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. INAAT
        1. By Value
      4. DNA Sequencing & NGS
        1. By Value
      5. In Situ Hybridization
        1. By Value
      6. DNA Microarrays
        1. By Value
      7. Other
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Diagnostics
        1. By Value
      3. Oncology Testing
        1. By Value
      4. Genetic Tests
        1. By Value
      5. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Academic Laboratories
        1. By Value
      3. Reference Laboratories
        1. By Value
      4. Others
        1. By Value
    6. China
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Reagents And Kits
          1. By Value
        3. Instruments
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. INAAT
          1. By Value
        4. DNA Sequencing & NGS
          1. By Value
        5. In Situ Hybridization
          1. By Value
        6. DNA Microarrays
          1. By Value
        7. Other
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Diagnostics
          1. By Value
        3. Oncology Testing
          1. By Value
        4. Genetic Tests
          1. By Value
        5. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Academic Laboratories
          1. By Value
        3. Reference Laboratories
          1. By Value
        4. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Reagents And Kits
        1. By Value
      3. Instruments
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. INAAT
        1. By Value
      4. DNA Sequencing & NGS
        1. By Value
      5. In Situ Hybridization
        1. By Value
      6. DNA Microarrays
        1. By Value
      7. Other
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Diagnostics
        1. By Value
      3. Oncology Testing
        1. By Value
      4. Genetic Tests
        1. By Value
      5. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Academic Laboratories
        1. By Value
      3. Reference Laboratories
        1. By Value
      4. Others
        1. By Value
    6. UAE
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Reagents And Kits
          1. By Value
        3. Instruments
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. INAAT
          1. By Value
        4. DNA Sequencing & NGS
          1. By Value
        5. In Situ Hybridization
          1. By Value
        6. DNA Microarrays
          1. By Value
        7. Other
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Diagnostics
          1. By Value
        3. Oncology Testing
          1. By Value
        4. Genetic Tests
          1. By Value
        5. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Academic Laboratories
          1. By Value
        3. Reference Laboratories
          1. By Value
        4. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product & Service
      1. Introduction
        1. Product & Service By Value
      2. Reagents And Kits
        1. By Value
      3. Instruments
        1. By Value
      4. Software & Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. PCR
        1. By Value
      3. INAAT
        1. By Value
      4. DNA Sequencing & NGS
        1. By Value
      5. In Situ Hybridization
        1. By Value
      6. DNA Microarrays
        1. By Value
      7. Other
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Infectious Disease Diagnostics
        1. By Value
      3. Oncology Testing
        1. By Value
      4. Genetic Tests
        1. By Value
      5. Others
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Hospitals and Academic Laboratories
        1. By Value
      3. Reference Laboratories
        1. By Value
      4. Others
        1. By Value
    6. Brazil
      1. By Product & Service
        1. Introduction
          1. Product & Service By Value
        2. Reagents And Kits
          1. By Value
        3. Instruments
          1. By Value
        4. Software & Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. PCR
          1. By Value
        3. INAAT
          1. By Value
        4. DNA Sequencing & NGS
          1. By Value
        5. In Situ Hybridization
          1. By Value
        6. DNA Microarrays
          1. By Value
        7. Other
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Infectious Disease Diagnostics
          1. By Value
        3. Oncology Testing
          1. By Value
        4. Genetic Tests
          1. By Value
        5. Others
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Hospitals and Academic Laboratories
          1. By Value
        3. Reference Laboratories
          1. By Value
        4. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Molecular Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Agilent Technologies Inc.
    3. Thermo Fisher Scientific Inc.
    4. F. Hoffmann-La Roche Ltd.
    5. bioMerieux SA
    6. Illumina Inc.
    7. Danaher Corporation
    8. Siemens Healthineers AG
    9. Novartis AG
    10. GRIFOLS S.A.
    11. HOLOGIC INC.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Clinical Diagnostics Market Size The global clinical diagnostics market size was valued at USD 84.18 billion in 2024 and is projected to reach from USD 98.21 billion in 2025 to USD 187.78 billion by 2033, exhibiting a CAGR of 6.48% during the f
Buy Now
Global Report
Hematology Diagnostics Market Size & Trends The global hematology diagnostics market size was valued at USD 8.34 billion in 2022. It is projected to reach USD 13.50 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2023–2031
Buy Now
Global Report
Market Overview The global influenza diagnostics market size was valued at USD 645.31 million in 2019 and is expected to grow at 7.7% CAGR during the forecast study period. Influenza diagnostics is regarded as a highly transmitted respiratory
Buy Now
Global Report
Point-Of-Care Molecular Diagnostics Market Size The global point-of-care molecular diagnostics market size was valued at USD 2.27 billion in 2022 and is projected to reach USD 4.48 billion by 2031, growing at a CAGR of 7.84% 
Buy Now
Global Report
Remote Diagnostics Market Size & Trends The global remote diagnostics market size was valued at USD 41.3 billion in 2023. It is expected to reach USD 121.3 billion by 2032, growing at a CAGR of 31.8% during the forecast period (2024–20
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.